NewswireToday - /newswire/ -
Sunnyvale, CA, United States, 2013/11/26 - HCL Technologies announced that it has been recognized as a “Leader” and “Star Performer” category in life sciences IT outsourcing by leading advisory and research firm Everest Group - HCL.com.
HCL Technologies, a leading global IT services company today announced that it has been recognized as a “Leader” and “Star Performer” category in life sciences IT outsourcing by leading advisory and research firm Everest Group in its report,“IT Outsourcing in Life Sciences Industry Service Provider Landscape with PEAK Matrix™ Assessment and Profile Compendium 2013.
HCL was recognized for its continual growth on a large scale, and for its significant investment in life science proprietary solutions.
This report assesses 14 ITO service providers in the life sciences vertical with a focus on large (TCV>US$25 million), annuity based, and multi-year (>3 year) application outsourcing relationships. The service providers were mapped on the Everest Group’s performance, experience, ability, knowledge (PEAK) Matrix, a composite index of range of distinct metrics related to provider’s capability and market success across two key dimensions market success measured by the number, scale and growth of large life sciences ITO contracts and delivery capabilities measured by scale of operations, scope, enabling domain investments, and delivery footprint.
“The Life Sciences industry is keenly adopting next-generation IT with an eye on enabling strategic initiatives," said Jimit Arora, Vice President of Everest Group. "HCL’s investments in its services portfolio and domain solutions have created success in large, multi-year IT service contracts for life sciences customers. HCL not only continued to maintain its position as a Leader on the PEAK Matrix but also enhanced its capabilities and achieved above average growth to be a Star Performer.”
R Srikrishna, President Infrastructure Services and Life Sciences & Healthcare, HCL said,“Everest recognition is a great acknowledgement of HCL’s strong momentum and success in its life sciences business, resulting from our strong focus on solution development and significant pharma deal wins in the application, infrastructure and ERP space globally. During the last financial year HCL’s healthcare and life sciences posted incremental revenue of 45.2%, which is way ahead when compared to the other leading operating players for the same time period”.
HCL (hcl.com) is a partner of choice for 9 out of the top 10 leading pharmaceutical companies across the globe. HCL’s dedicated Life Sciences practice provides a complete range of services spanning the entire Pharma value chain, creating new propositions and innovative solutions for its clients. HCL’s deep domain expertise, historical R&D experience, outcome-based partnerships with global giants, and diverse geographical outreach, has enabled its customers achieve the objectives of their ‘run’, ‘improve’ and ‘transform’ initiatives.